EMA — authorised 17 June 2021
- Marketing authorisation holder: Regeneron Ireland Designated Activity Company (DAC)
- Status: approved
EMA authorised Evkeeza on 17 June 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 17 June 2021.
Regeneron Ireland Designated Activity Company (DAC) holds the EU marketing authorisation.